Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Eine Gentherapiestudie zur Untersuchung der Wirkung und Sicherheit von Fidanacogen Elaparvovec bei Männern mit Hämophilie B
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: German
ViewDownloadPrint
Μια μελέτη γονιδιακής θεραπείας για την άντληση γνώσης σχετικά με τις επιδράσεις και την ασφάλεια του fidanacogene elaparvovec σε άντρες με αιμοφιλία B
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: Greek
ViewDownloadPrint
En genterapistudie för att få information om effekter och säkerheten för fidanacogene elaparvovec hos män med hemofili B
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: Swedish
ViewDownloadPrint
A study to learn about the efficacy and safety of preventive routine replacement treatment with blood clotting factor VIII (8) in adults with hemophilia A
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: English
ViewDownloadPrint
Étude pour connaître l’efficacité et la sécurité du traitement courant prophylactique de substitution par le facteur VIII (8) de la coagulation sanguine chez les adultes atteints d’hémophilie A
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: French
ViewDownloadPrint
Eine Studie zur Untersuchung der Wirksamkeit und Sicherheit der präventiven Routine-Ersatzbehandlung mit dem Blutgerinnungsfaktor VIII (8) bei Erwachsenen mit Hämophilie A
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: German
ViewDownloadPrint
μελέτη για την άντληση γνώσης σχετικά με την ασφάλεια και την αποτελεσματικότητα της προφυλακτικής θεραπείας υποκατάστασης ρουτίνας με παράγοντα πήξης αίματος VIII (8) σε ενήλικες με αιμορροφιλία A
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: Greek
ViewDownloadPrint
Uno studio per conoscere l’efficacia e la sicurezza del trattamento di routine sostitutivo di profilassi del fattore VIII (8) di coagulazione in adulti affetti da emofilia A
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: Italian
ViewDownloadPrint
Estudio para conocer la eficacia y seguridad del tratamiento sustitutivo convencional preventivo con factor VIII (8) de coagulación sanguínea en adultos con hemofilia A
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: Spanish
ViewDownloadPrint
En studie för att lära sig om effekten och säkerheten av förebyggande rutinersättningsbehandling med blodkoagulationsfaktor VIII (8) hos vuxna med hemofili A
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: Swedish
ViewDownloadPrint
A Study to Assess the Safety and Tolerability of PF-07055480/Giroctocogene Fitelparvovec Gene Therapy in Adults With Severe Hemophilia A
Category & Conditions: Rare Diseases
Study Phase : 1/2
Medicine: giroctocogene fitelparvovec (PF-07055480)
Language: English
ViewDownloadPrint
A Study Comparing Palbociclib Plus Cetuximab Versus Cetuximab for the Treatment of Head and Neck Cancer
Category & Conditions: Cancer
Study Phase : 2
Medicine: Ibrance (palbociclib)
Language: English
ViewDownloadPrint